Anavex Life Sciences Corp (AVXL)

[baltimorebullet]

"A picture is worth a thousand words".

And sometimes a thousand words paint a picture...

"This is an important development as the patients who have completed the main study, ANAVEX2-73-AD-004, are consistently expressing the wish to gain ongoing access to this investigational therapy," says A/Professor Stephen Macfarlane, FRANZCP, Head of Clinical Services at the Dementia Centre, HammondCare and Principal Investigator for both studies".

We keep hearing of eagerness to continue with A2-73.

BB